Skip to content

Clinical trials

Depressive Disorder trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Status: Unknown status Clear all

116 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20082
20101
20114
20123
20131
20145
20155
20164
20177
201811
201912
202014
20216
202214
202318
20246

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status116

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina4
Shanghai Mental Health Center4
Centre Hospitalier Universitaire de Besancon3
First Affiliated Hospital of Zhejiang University3
Universitat Jaume I3
Guangzhou Psychiatric Hospital2
Instituto de Investigación Sanitaria Aragón2
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz2
Max-Planck-Institute of Psychiatry2
Sheba Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder116
Anxiety Disorders29
Major Depressive Disorder13
Bipolar Disorder9
Mental Disorders7
Depressive Disorder, Treatment-Resistant6
Mood Disorders5
Stress Disorders, Post-Traumatic5
Substance-Related Disorders4
Inflammation3

Trials

Showing 51 to 75 of 116. Each trial links to its page on Pharma Observatory.

16 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.